-
Our Vision is to improve healthcare as a global provider of innovative and reliable diagnostic tests. -
Our Mission is to identify and develop novel patentable diagnostic markers and technologies which can be commercialised to meet clinical needs, both in the laboratory and at the point of care. -
We will collaborate with partners, create branded products and identify complementary businesses which support our objective of continuing to grow as a respected and profitable healthcare company. -
Our Values include meeting all current and future regulatory, quality and environmental standards appropriate for our industry and the countries in which we operate.
Axis-Shield Point of Care has a range of well documented PT-INR tests for use in the control of anticoagulation therapy.
The tests can be used in a Point of Care setting on Thrombotrack instruments or adapted to large coagulation analysers for clinical laboratories.
Thrombotest and Nycotest PT are for research use only in the USA.
Material Safety Data Sheets for all Axis-Shield PoC products can be found here
*Products may not be approved for sale in all countries. Please contact your local distributor for further details.
Axis-Shield at a Glance
A pioneering organisation focused on the development and manufacturing of important and innovative in vitro diagnostic tests for use in clinical laboratories and at the point of care.
Focus on Afinion
Axis-Shield's award winning point-of-care test system is designed for maximum simplicity coupled with laboratory accuracy and reliability for a number of key markers important for improved patient management.
